PENNSYLVANIA, January 31 - late-stage, persistent infection with Borrelia burgdorferi or

complications related to the infection or with other strains of

Borrelia, including B. miyamotoi, B. mayonii, B. garinii and B.

afzelii, that are recognized by the Centers for Disease Control

and Prevention as a cause of Lyme disease. The term includes

infection that meets the surveillance criteria established by

the Centers for Disease Control and Prevention and other acute

and persistent manifestations of the infection as determined by

a health care practitioner.

"Related tick-borne disease." The presence of signs or

symptoms compatible with infection with bartonella,

babesiosis/piroplasmosis, anaplasmosis, ehrlichiosis, Rocky

Mountain spotted fever, rickettsiosis, Powassan or other tick-

transmissible illness or complications related to the

infections. The term does not include Lyme disease.

Section 3. Continuing education requirement.

(a) General rule.--A licensing board shall require that a

licensee complete at least two hours of continuing education in

the assessment and diagnosis of and treatment options for Lyme

disease and other related tick-borne diseases as a portion of

the total continuing education required for license renewal.

(b) Content.--A licensing board shall establish the content

of continuing medical education required under this section. The

content shall address, at a minimum, the most current, evidence-

based research on tick data/pathogens Statewide, patient profile

and symptom presentation in regards to assessment and diagnosis,

current diagnostic options and current treatment options and

prevention.

(c) Input.--In establishing the content required for

continuing medical education required under this section, the

20230SB0233PN0200 - 3 -

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30